posted
News for 'IGTG' - (Ingen Completes 2006 Fiscal Year)
YUCAIPA, Calif., June 13, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTG), a medical device manufacturer and developer of next generation medical technology, announced today the completion of the 2006 Fiscal year End and the beginning of the new year.
The Company's 2006 fiscal year was from June 1, 2005 through May 31, 2006 where revenues from the sale of Secure Balance(R) were slightly increased compared to last fiscal year. During the last quarter the company engaged Secure Health, Inc. to establish a Secure Balance(R) sales force. They currently have 23 sales people established domestically to sell Secure Balance(R) to physicians and chiropractors within the United States. The company continues to sell Secure Balance(R) to physicians, chiropractors and physical therapists throughout the United States and abroad.
The company advertising budget enabled direct advertising of Secure Balance(R) with the Journal of Neurology(R), Dynamic Chiropractics(R), Chiropractic Economics(R), The American Chiropractor(R) and DC Products Review(R). These are national publications with a majority of the physician and chiropractic market. The company has agreed to extend another 12 months with the same advertisers. Further, the company was able to produce 3 major syndicated news and infomercials on national television and radio with Today's Health(R), Health Journal TV(R), and Max World News(R). The company has signed an extended contract with Health Journal TV(R) to produce a personal interview with the host, former Secretary of State under President Ronald Regan, Mr. Alexander Haig. Anyone can request a copy of this video with HJTV by contacting the company.
The company was able to budget and pay for the OxyView(R) tooling in March 2006. The company invested $125,000 in tooling necessary to bring OxyView(R) into production. The tooling is complete, and the company is developing the assembly, testing and packaging processes with Acorn-Gencom, Inc. in Corona, California where the OxyView(R) will be manufactured. Acorn-Gencom and Ingen have finalized the actual production costs for OxyView(R). The Food and Drug Administration has registered the company in April 2006, as well as classified the OxyView(R) product and has allowed the company to market the device.
The company was issued a US Patent Pending for OxyView(R) from the United States Patent and Trademark office. Further, the company filed Foreign Patents in Japan and China in May 2006, pursuant to the working negotiations with a major distributor in those countries. The company will prepare to file a Foreign Patent within the European Union in July 2006 upon production and sale of the OxyView(R). The company is finalizing distribution contracts with two major distributors for the United States, Japan, China and Europe. These distributors represent 80% of the medical market for OxyView(R).
The company had budgeted $100,000 to build the first working prototype of OxyAlert(R). This prototype was demonstrated in February 2006. The company has established agreements with 3D Instruments, LLC in Anaheim, California to manufacture and produce OxyAlert(R).
The auditors have commenced the audit for year-end May 31, 2006. Upon completion of the 2006 audit, the Company will file the 10-KSB for 2006.
The company is evaluating the expansion of the Yucaipa office and has hired more individuals to assist with the daily administrative requirements. The company has currently renewed its business license with the City of Yucaipa, and membership with the Better Business Bureau and Chamber of Commerce. Most recently the company has established a listing with Dun & Bradstreet.
"Ingen Technologies has made great strides since our merger in 2004. We continued Secure Balance(R) sales, completed the production of OxyView(R) and continue moving forward in a growth oriented direction. Our focus for 2007 is increased revenues, new medical products and being listed on the OTC:Bulletin Board," said Scott Sand, Chairman and CEO of Ingen Technologies.
About Ingen Technologies, Inc.
Ingen Technologies, Inc. develops and markets cutting-edge medical technologies designed to increase accuracy of medical care, and prevent unnecessary medical costs associated with today's healthcare. Ingen is a medical device manufacturer and a growth-oriented company that owns 2-US patent(s) and 1-US Patent Pending and 2 Foreign Patent Pending(s), several trademarks, intellectual property and proprietary medical products. The Secure Balance(TM) product generates profitable revenues for the company, and is a private-label product that includes a vestibular function testing system and balance therapy system that can identify and prevent fall injuries in the ever growing elderly population. The Company's flagship product, OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line provides a low-oxygen safety warning devices used on remote oxygen cylinders for patients, hospitals, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance. OxyAlert(TM) increases safety and convenience for patients and clinical staff. OxyView, Patent Pending and FDA registered, is a pneumatic gauge that provides visual monitoring of oxygen flow-rate for patients (young and old) in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient and cannula. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the cannula.
posted
I picked some more up yesterday after a big unexpected drop. Money has been flowing in over the last month and this has done well for me in the past. I'm not entirely thrilled with Sand's performance but at this low I could not resist.
-------------------- Trust but verify! Posts: 368 | Registered: Oct 2005
| IP: Logged |
posted
It's all coming together! Definately a long term hold. I also picked up another 10,000 shares yesterday because of the drop. Once everything is up and running and on the OTC:BB this should go to a $1.00 or more. GLTA and keep this on radar.
-------------------- The thing I learned most about this is to take a profit when you can and you gotta have PATIENCE! Posts: 369 | From: Ft. Myers, FL | Registered: Oct 2005
| IP: Logged |
posted
whats with the sudden 30% drop. That pr that came out wasn't bad news. I bought this back before the r/s and have lost about 900 dollars since then. Just praying it starts creeping up to $1.00 as you say.
Posts: 69 | Registered: Dec 2005
| IP: Logged |
posted
Long term, but probley won't reach any higher until they put out exact numbers after the Oxy system has been in selling circulation and they get on to the BB. This one I have just forgotten about and will wait for its time. As to why the pps dropped? I don't know for sure. I wish I had waited till today to buy instead of yesterday.
-------------------- The thing I learned most about this is to take a profit when you can and you gotta have PATIENCE! Posts: 369 | From: Ft. Myers, FL | Registered: Oct 2005
| IP: Logged |
posted
I've been in this pre r/s and am holding 16K shares at .53 pps. Ouch! I still believe in the product(s) they have, but in your DD, go back to 2004 and read all the pr's. Most of them are on the website. PR's are always very optimistic about sales. Also, they had hoped to be on the BB in 2004.
IMO, the reason for the drop is this line, "where revenues from the sale of Secure Balance(R) were slightly increased compared to last fiscal year" In a prior PR, they touted increased sales.
I had emailed Sand's early last month. His response was there should be 4 PR's this month. Hope the next three are better. (Somewhere on here, there is another IGTG thread where I posted his response)
Wish everyone the best, I'm down so far that I'll just wait it out.
Posts: 176 | From: Ohio | Registered: Sep 2005
| IP: Logged |
posted
I found the response I got from Scott Sands on 04/26/06. here it is. I was wrong, he only mentioned 2 announcements. Sorry for the incorrect info in the above post.
"Thank you for your concern.
Although I cannot suggest to you how to trade your stock, I can offer some update on our progress.
Attorney Richard Weed is in communication with the NASD regarding our application for the OTCBB. Once we have filed our 10-KSB ending May 31, 2006; the company qualifies for the OTCBB. Our auditors are preparing for that audit, and we anticipate filing the 10-KSB in July.
We continue to keep our SEC filings current, since the 2004 merger, and we are finalizing the past due filings from 1999-2003. We have hired a forensic accountant to obtain bank records for those years. We anticipate completing the older filings this summer.
OxyView tooling is complete, and the FDA has recently accepted registration and classification of the product. They have allowed us to market the product. We have been granted a Patent Pending in the US, and we have recently filed foreign patents in Japan and China. We anticipate the first production run of Oxyview in June. Our FDA owner/operator number is 9085663, and can be verified through calling the FDA at 240-276-0111. Oxyview will be manufactured (and cleaned packaged) in Corona-California by Acorn-Gencom, Inc.. We own all of the tooling, processes and intellectual property.
We have two Oxyview distributors under consideration, and we will make an announcement next month regarding who they are.
OxyAlert is being finalized, and I will make an announcement next month.
Secure Balance continues to feed the company, and we continue to remain debt free (except for money owed to me). I plan to convert any of my debt to shares, pursuant a Board decision.
In reference to any past PR releases; please read them carefully since we provide projected/Performa data based upon market research. Always make any investment evaluation on the actual SEC filings (i.e., 10-QSB and 10-KSB). The PR is for current event status and projected possibilities.
Thank you for your continued support.
Regards,
Scott Sand, CEO & Chairman Ingen Technologies, Inc.
Posts: 176 | From: Ohio | Registered: Sep 2005
| IP: Logged |
posted
Ingen Technologies, Inc. Secure Balance(R) National Satellite News Uplink 08:15 a.m. 06/15/2006 Provided by
- National Television Networks Tell the Story - YUCAIPA, Calif., June 15, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (IGTG), a medical device manufacturer and developer of next generation medical technology, announced today that the Secure Balance(R) news story reported by Max World News was up-linked via satellite on Tuesday, June 13th, 2006.
The Boynton Beach, Florida based MAX World News agency is a world-leading news-gathering and delivery service and is recognized as the "one-source" for news delivery. When it comes to producing compelling news stories, their award winning, nationwide network of seasoned television professionals create the impact to get the job done. Max World News has aired stories on every major television network in the United States including, ABC, NBC, CBS, FOX, CNN and CNBC among others and have been seen in over 210 countries around the world, and has personal relationships with health, technology, and consumer interest editors, producers and reporters at every major network in the United States. MAX World News communicates directly with stations to effectively cover breaking news and plan newscasts around observances, seasonal topics and current events.
The Company's Secure Balance(R) product line is a recognized brand name within the medical industry as it relates to Balance & Fall Prevention medicine. The news story is also available on the Ingen website. The Company is prepared for the consumer response and potential sales that will result from this national news release.
"This is a great surprise for Ingen. Max World News had developed the story last February, and we were not sure how the major television networks would accept the story. Balance is a problem with the elderly population, and our Secure Balance(R) product can improve lives and save unwanted Medicare costs paid for by the tax payers," said Scott Sand, Chairman and CEO.
More market exposure!
-------------------- Trust but verify! Posts: 368 | Registered: Oct 2005
| IP: Logged |
posted
Interesting find, apparently IGTG is NOT going to issue the 25m shares. They may be waiting on the response from the SEC to put out a PR.
Check it out on EDGAR:
U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N. E. Washington, D.C. 20549
Attention: Tom Jones Telephone 202.551.3602 Facsimile 202.772.9206
Re: Ingen Technologies, Inc., a Georgia corporation Registration Statement on Form SB-2 (File No. 333-133022) Filed April 5, 2006
Request For Withdrawal of Registration Statement ------------------------------------------------
Greetings:
Pursuant to Rule 477 of the Securities Act of 1933, as amended (the "Securities Act"), Ingen Technologies, Inc., a Georgia corporation ("IGTG") requests the consent of the Securities and Exchange Commission (the "Commission") to withdraw its Registration Statement on Form SB-2 (File No. 333-133022), together with all exhibits thereto (collectively, the "Registration Statement"). The Registration Statement was filed with the Commission on April 5, 2006.
The Registration Statement covers the sale by IGTG of 25,000,000 shares to the public, and the resale of common stock and common stock underlying stock options by certain selling security holders. IGTG requests the withdrawal so that IGTG may explore other alternatives to the public sale of its securities for cash. IGTG is aware of Rule 155 of the Securities Act Rules concerning the non-exclusive safe harbor from integration of private and registered offerings.
This letter of request for withdrawal will confirm that the Registration Statement was not declared effective by the Commission and no securities were sold in connection with the Registration Statement.
<PAGE>
IGTG requests that the Commission issue a written order granting the withdrawal of the Registration Statement as soon as possible. IGTG requests, in accordance with Rule 457(p) of the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to IGTG's account for future use.
Please fax a copy of the order to our office to the attention of the undersigned at 800-777-1186.
Sincerely yours,
/s/ Scott Sand -------------- Scott Sand Chief Executive Officer
cc: Richard O. Weed, 949-475-9087
-------------------- Trust but verify!
-------------------- Trust but verify! Posts: 368 | Registered: Oct 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
